SSIISS Innovations International, Inc.
Price
-77%1YEnd-of-day closes, not the intraday tick.
Mostly good, one thing to check: safety
Quality strong, a flag to check, growing in the filings, the market undecided.
Charts
As reported to the SEC, without any scoring.
SS Innovations International, Inc. (SSII) reported revenue of $14M in Q2 2026 (quarter ended Jun 30, 2026), up 39% from the same quarter a year earlier. That came with a gross margin of 51% and net loss of $2.7M. For the full year FY2025, revenue was $42M (+106% year on year) and net income −$12M. The next results filing is expected around Oct 27, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Oct 13, 2026On October 13, 2026, SSi issued a press release announcing that, on October 5, 2026, the Company submitted its response to a request for additional information letter received from the United States Food and Drug Administration with respect to its 510(k) application for SSi’s SSi Mantra surgical robotic system.Other event · Form 8-K
- Oct 13, 2026Securities Purchase Agreement On October 9, 2026 (the “Closing Date” or the “Effective Date”), SSi entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an institutional investor (the “Investor”), and consummated the transactions contemplated thereby (the “Closing”)Material agreement entered · Form 8-K
- Oct 5, 2026We Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation October 2026 Nasdaq: SSII.Regulation FD disclosure · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Medical Devices
Ranks #50 of 50 by RyuScore